The sessions highlighted the collaborative and challenge-oriented research carried out at Vall d’Hebron with the aim of generating transformative impact…
en_news
A public-private consortium led by the biotechnology company Nuage Therapeutics, together with the Spanish National Cancer Research Center (CNIO), the…
Results from a VHIO-led study show that MYC targeting by Omomyc induces tumor DNA damage in patient-derived preclinical models of…
ImmunoPET enables in vivo detection of LIF expression, a molecule linked to tumour growth, immune evasion and treatment resistanc A…
The Nocturna Rosa dinner has become an unmissable event for many individuals and companies in Malgrat de Mar. On 18…
The 2025 edition of the Health Research call from the “la Caixa” Foundation has selected 34 new cutting-edge biomedical research…
From 7 to 16 November, the 30th Setmana de la Ciència took place, and VHIO took part with a programme…
The HOPE Prostate (SOLTI-2102) study analyzed 208 samples (116 tissue and 92 liquid biopsies) from 146 patients with metastatic prostate…
The Spanish Society of Medical Oncology (SEOM) has awarded 70 SEOM Grants with a total funding of 1,300,000 euros to…
The Sin Teta Hay Paraíso Association, founded in 2012 in Montcada i Reixac, is a non-profit organisation whose goal is…
